You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
Speaker | Marissa Jones, Ph.D.
Affiliation | biocrates life sciences ag | Business Development Manager
Metabolomics in pharma – Bridging R&D translation barriers
Part of the Webinar
Metabolomics in pharma – Bridging R&D translation barriers
In this lunch & learn event Marissa Jones shared insights on using metabolomics to uncover the “why” behind your research. Examine real-world case studies and see biocrates technology in action. Learn how metabolomics is making an impact in the pharmaceutical industry.
Related articles
- Predictive medicine – Transform medicine with metabolomics – part 2 of 5
- N-acetyl-aspartic acid (NAA) – Significant metabolite for brain function, metabolism, and disease
- Preventive medicine – Transform medicine with metabolomics – part 1 of 5
- Citric acid – Key metabolite in energy production, bone health, and disease therapy
- Precision nutrition – Unlocking health through metabolomics